Investigating the genetic variation underlying episodicity in major depressive disorder: suggestive evidence for a bipolar contribution.
- Authors
- Ferentinos, Panagiotis; Rivera, Margarita; Ising, Marcus; Spain, Sarah L; Cohen-Woods, Sarah; Butler, Amy W; Craddock, Nicholas; Owen, Michael J; Korszun, Ania; Jones, Lisa; Jones, Ian; Gill, Michael; Rice, John P; Maier, Wolfgang; Mors, Ole; Rietschel, Marcella; Lucae, Susanne; Binder, Elisabeth B; Preisig, Martin; Tozzi, Federica; Muglia, Pierandrea; Breen, Gerome; Craig, Ian W; Farmer, Anne E; Müller-Myhsok, Bertram; McGuffin, Peter; Lewis, Cathryn M
- Year
- 2014
- Journal
- Journal of affective disorders
- PMID
- 24215895
- DOI
- 10.1016/j.jad.2013.10.027
BACKGROUND: Highly recurrent major depressive disorder (MDD) has reportedly increased risk of shifting to bipolar disorder; high recurrence frequency has, therefore, featured as evidence of 'soft bipolarity'. We aimed to investigate the genetic underpinnings of total depressive episode count in recurrent MDD. METHODS: Our primary sample included 1966 MDD cases with negative family history of bipolar disorder from the RADIANT studies. Total episode count was adjusted for gender, age, MDD duration, study and center before being tested for association with genotype in two separate genome-wide analyses (GWAS), in the full set and in a subset of 1364 cases with positive family history of MDD (FH+). We also calculated polygenic scores from the Psychiatric Genomics Consortium MDD and bipolar disorder studies. RESULTS: Episodicity (especially intermediate episode counts) was an independent index of MDD familial aggregation, replicating previous reports. The GWAS produced no genome-wide significant findings. The strongest signals were detected in the full set at MAGI1 (p=5.1×10(-7)), previously associated with bipolar disorder, and in the FH+ subset at STIM1 (p=3.9×10(-6) after imputation), a calcium channel signaling gene. However, these findings failed to replicate in an independent Munich cohort. In the full set polygenic profile analyses, MDD polygenes predicted episodicity better than bipolar polygenes; however, in the FH+ subset, both polygenic scores performed similarly. LIMITATIONS: Episode count was self-reported and, therefore, subject to recall bias. CONCLUSIONS: Our findings lend preliminary support to the hypothesis that highly recurrent MDD with FH+ is part of a 'soft bipolar spectrum' but await replication in larger cohorts.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder. | 2015 | 25993607 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Deep Phenotyping at Scale: Study Protocol for the Korean Mood Disorder Genetic Study-Depression (KOMOGEN-D). | Min S et al. | — | 2026 | → |
| A Potential Role for MAGI-1 in the Bi-Directional Relationship Between Major Depressive Disorder and Cardiovascular Disease. | Banerjee P et al. | — | 2024 | → |
| Prevalence of major depressive disorder and its associated factors among adult patients with neurolathyrism in Dawunt District, Ethiopia; 2022: community-based cross-sectional study. | Bimerew M et al. | — | 2024 | → |
| The genetic basis of major depressive disorder. | Flint J | — | 2023 | → |
| The association of personality polygenic risk score, psychosocial protective factors and suicide attempt in mood disorder. | Su MH et al. | — | 2022 | → |
| MAGI1, a Scaffold Protein with Tumor Suppressive and Vascular Functions. | Wörthmüller J et al. | — | 2021 | → |
| Exploring genetic variants in obsessive compulsive disorder severity: A GWAS approach. | Alemany-Navarro M et al. | — | 2020 | → |
| Reviewing the genetics of heterogeneity in depression: operationalizations, manifestations and etiologies. | Cai N et al. | — | 2020 | → |
| Association of Polygenic Liabilities for Major Depression, Bipolar Disorder, and Schizophrenia With Risk for Depression in the Danish Population. | Musliner KL et al. | — | 2019 | → |
| Magi-1 scaffolds Na<sub>V</sub>1.8 and Slack K<sub>Na</sub> channels in dorsal root ganglion neurons regulating excitability and pain. | Pryce KD et al. | — | 2019 | → |
| Polygenic risk score: use in migraine research. | Chalmer MA et al. | — | 2018 | → |
| The genetics of human personality. | Sanchez-Roige S et al. | — | 2018 | → |
| The use of polygenic risk scores to identify phenotypes associated with genetic risk of bipolar disorder and depression: A systematic review. | Mistry S et al. | — | 2018 | → |
| Modeling prior information of common genetic variants improves gene discovery for neuroticism. | Lo MT et al. | — | 2017 | → |
| The effects of the interplay of genetics and early environmental risk on the course of internalizing symptoms from late childhood through adolescence. | Musci RJ et al. | — | 2016 | → |
| Familiality and SNP heritability of age at onset and episodicity in major depressive disorder. | Ferentinos P et al. | — | 2015 | → |
| Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder. | Genetics of Personality Consortium et al. | — | 2015 | → |